Medable has set up a subsidiary in Pfäffikon SZ. The U.S. company offers software that makes it easier to conduct clinical trials.
Medable has established a subsidiary in Pfäffikon, as was reported in a newsletter from the Office for Economy of the canton of Schwyz. The U.S. company has developed software for clinical trials. This makes it easier to recruit patients and helps in the collection and storage of data. The overall aim is to accelerate drug development through decentralized clinical trials.
With this expansion into the Greater Zurich Area, Medable wants to enable greater engagement with European pharma companies. In a press release, the importance of the cooperation with Swiss pharma groups was also highlighted.
Related documents
The PDF outlines why Greater Zurich is a top location for European expansion.
Learn more about the advantages of doing business in the Greater Zurich Area.
Insights from biotech leaders regarding timing, regulations, and choice of location.
Related Success Stories
News
Meet with an expansion expert
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space